|January 23, 2014|
|09:25 EDT||SNTI, SNTI, SRNE, SRNE, SPEX, SPEX, CDXC, CDXC, CBMX, CBMX, SSET, SSET, OPK, OPK, CGIX, CGIX||RedChip Companies to hold a virtual conference|
RedChip Emerging Growth Showcase is being held on January 22-23 with webcasted presentations to begin on January 23 at 9:30 am. Webcast Link
News For OPK;CGIX;SNTI;SRNE;SPEX;CDXC;CBMX;SSET From The Last 14 Days
|June 30, 2015|
|07:45 EDT||CGIX||Cancer Genetics awarded multimillion dollar clinical trial |
Cancer Genetics announced that it has been awarded a multimillion dollar, clinical trial in hematological cancers by a leading biotech company – the trial is the largest in the company's history of providing clinical trial and genomic services to global biopharma companies. As part of the agreement, CGI will perform all testing, and provide genomic information and monitoring for CLL patients enrolled in multi-arm, randomized, multicenter, global trials. The CLL trials are expected to contribute up to $6.2M in revenue over several years as patients are selected, treated, and monitored using pathway-specific, targeted therapies, and combination therapies.
|June 29, 2015|
|18:28 EDT||SRNE||Sorrento Therapeutics CFO Mark Durand retires|
Subscribe for More Information
|June 26, 2015|
|12:58 EDT||OPK||On The Fly: Top stock stories at midday|
Stocks on Wall Street were mixed at midday, with Nike's (NKE) post-earnings rise providing a boost to the Dow and Micron's (MU) slide dragging on the tech-heavy Nasdaq. ECONOMIC EVENTS: In the U.S., the University of Michigan consumer sentiment reading rebounded to 96.1 in the final June report from the preliminary 94.6 reading. That revised figure topped the expected reading of 95. In Europe, the ECB left the level of emergency cash available to Greek banks unchanged again Friday as deposit outflows have slowed, according to people familiar with the matter reporting to Bloomberg. Greek leaders are scheduled to hold talks Saturday with the Eurogroup in what may be the nation's last chance for a deal ahead of the expiration of the current bailout agreement on June 30. In China, stocks plunged by the most in five months as the Shanghai Composite Index fell 7.4%, with market watchers citing margin worries and concerns that the PBOC will be less likely to undertake further rate cuts. COMPANY NEWS: Shares of Nike advanced 4% after the athletic apparel and sneaker maker reported fourth quarter results that handily beat expectations. Several firms raised their respective price targets on the stock following the company's Q4 report, including Goldman, which reiterated its Conviction Buy rating on Nike and raised its price target to $131 from $121. Finish Line (FINL), an athletic shoe and apparel retailer that sells Nike products, rose 5% after its own first quarter results also topped the consensus forecast. MAJOR MOVERS: Among the notable gainers was OPKO Health (OPK), which rose nearly 4% after the company announced the decision of the National Comprehensive Cancer Network to include 4Kscore as a recommended test in the 2015 NCCN Guidelines for Prostate Cancer Early Detection. Additionally, CEO Phillip Frost disclosed in regulatory filings that he'd acquired over 64,000 shares of the company stock in the last two days. Also higher was Kforce (KFRC), which gained 7% after SunTrust upgraded the stock to Buy and raised its price target to $27 from $24, noting that the firm's private IT staffing poll suggests margin assumptions may prove conservative. Among the noteworthy losers was Micron, which sunk about 19% after the flash memory maker reported weaker than expected results last night and provided lower than expected Q4 revenue guidance. Also lower were shares of coal miner Peabody (BTU), which fell 7% after Moody's downgraded the company's credit rating to reflect the firm's expectation for the deterioration in the company's credit metrics to be more precipitous than it had previously thought due to the ongoing decline in the seaborne metallurgical coal markets. INDEXES: Near midday, the Dow was up 53.70, or 0.3%, to 17,944.06, the Nasdaq was down 40.56, or 0.79%, to 5,071.62, and the S&P 500 was down 2.18, or 0.1%, to 2,100.13.
|11:46 EDT||OPK||Opko Health shares advance after CEO buys shares |
Shares of OPKO Health are advancing after the company CEO Phillip Frost disclosed in a filing this morning that he'd acquired 7,200 shares of the company stock for $15.39 per share on June 25. The CEO's share purchases follow a disclosure yesterday morning that he'd purchased 57,200 shares of the company stock for $15.33 per share on June 24. Opko Health shares are up 3.6% to $15.97 in late morning trading.
|10:26 EDT||OPK||OPKO 4Kscore recommended in NCCN guidelines for prostate cancer early detection|
OPKO Health announced the decision of the National Comprehensive Cancer Network to include 4Kscore as a recommended test in the 2015 NCCN Guidelines for Prostate Cancer Early Detection. The panel concluded that the 4Kscore, as a blood test with greater specificity over the PSA test, is indicated for use prior to a first prostate biopsy or after a negative biopsy to assist patients and physicians in further defining the probability of high-grade cancer. The 4Kscore test has been studied on over 22,000 patients with results published in 12 peer-reviewed scientific publications.
|June 25, 2015|
|06:05 EDT||CBMX||CombiMatrix expands sales team|
CombiMatrix has hired seven sales representatives since June 1 and plans to add four more individuals to the team in Q3. The company is also adding professionals in key positions in other revenue-generating departments, including billing and reimbursement, genetic counseling and in the laboratory. CombiMatrix CEO Mark McDonough stated, ""Our sales force expansion provides us with greater opportunities to capitalize on the anticipated growth in the markets we serve. We expect to end 2015 with a sales organization that is nearly doubled in size compared to the beginning of the year,"
|June 24, 2015|
|09:13 EDT||SRNE||Sorrento Therapeutics subsidiary receives MUMS drug designation in dogs|
Subscribe for More Information
|June 22, 2015|
|06:06 EDT||SPEX||Spherix notified by USPTO of issuance of new patent|
Spherix announced that the United States Patent & Trademark Office, or USPTO, has notified the company that it will issue a new patent to Spherix that is part of a standard essential family of patents. The new patent will issue on June 30 as U.S. Patent RE45,598 from U.S. Patent Application Serial No.13/728,698.
|June 21, 2015|
|14:16 EDT||OPK||OPKO Health shares look pricey, Barron's says|
Investors should steer clear of OPKO Health (OPK) and Bio-Reference Labs (BRLI) in light of their recent merger agreement, Barron's contends in a feature article. Though OPKO hopes to push its prostate cancer test, similar products have performed poorly on the market, and Barron's advises "only those who believe that [CEO and chairman Phillip Frost] can work miracles" to own the stock. Reference Link
|June 18, 2015|
|06:36 EDT||CDXC||ChromaDex to collaborate on Niagen clinical study with University of Colorado|
Subscribe for More Information